Genmab A/S (GMAB)
31.55
-0.97
(-2.98%)
USD |
NASDAQ |
Dec 30, 15:56
Genmab Market Cap: 19.40B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merus NV | 6.826B |
| AbbVie, Inc. | 406.27B |
| Johnson & Johnson | 499.35B |
| Novo Nordisk A/S | 227.37B |
| Krystal Biotech, Inc. | 7.191B |
Market Cap Related Metrics
| PE Ratio | 13.40 |
| PS Ratio | 5.524 |
| PEG Ratio | 0.1057 |
| Price to Book Value | 3.374 |
| Price to Free Cash Flow | 16.32 |
| Price | 31.55 |
| Earnings Yield | 7.46% |
| PEGY Ratio | 0.1057 |
| Operating PE Ratio | 14.99 |
| Normalized PE Ratio | 13.33 |